Patterson Companies (PDCO) Expected to Announce Earnings on Wednesday

Patterson Companies (NASDAQ:PDCOGet Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, February 26th. Analysts expect Patterson Companies to post earnings of $0.62 per share and revenue of $1.63 billion for the quarter. Patterson Companies has set its FY25 guidance at $2.25-$2.35 EPS and its FY 2025 guidance at 2.250-2.350 EPS.

Patterson Companies (NASDAQ:PDCOGet Free Report) last announced its quarterly earnings data on Thursday, December 5th. The company reported $0.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.02). The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.65 billion. Patterson Companies had a net margin of 2.37% and a return on equity of 19.77%. Patterson Companies’s revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.50 earnings per share. On average, analysts expect Patterson Companies to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Patterson Companies Stock Performance

Shares of Patterson Companies stock opened at $31.05 on Wednesday. The firm has a fifty day moving average of $30.78 and a two-hundred day moving average of $25.03. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.76 and a current ratio of 1.37. The stock has a market capitalization of $2.74 billion, a price-to-earnings ratio of 18.16, a PEG ratio of 2.70 and a beta of 0.90. Patterson Companies has a 52 week low of $19.45 and a 52 week high of $31.79.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Robert W. Baird raised their target price on Patterson Companies from $25.00 to $31.00 and gave the stock a “neutral” rating in a report on Thursday, December 12th. Leerink Partners reaffirmed a “market perform” rating and issued a $31.35 target price (up previously from $29.00) on shares of Patterson Companies in a research note on Wednesday, December 11th. Leerink Partnrs cut shares of Patterson Companies from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Mizuho began coverage on shares of Patterson Companies in a report on Wednesday, December 4th. They issued a “neutral” rating and a $23.00 price target for the company. Finally, Morgan Stanley raised their price objective on Patterson Companies from $27.00 to $31.35 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Eleven analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, Patterson Companies has a consensus rating of “Hold” and an average target price of $26.57.

Get Our Latest Report on PDCO

Insider Activity

In other news, CEO Donald Zurbay sold 1,962 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $23.08, for a total value of $45,282.96. Following the completion of the transaction, the chief executive officer now owns 222,736 shares in the company, valued at $5,140,746.88. This represents a 0.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.90% of the company’s stock.

About Patterson Companies

(Get Free Report)

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.

Further Reading

Earnings History for Patterson Companies (NASDAQ:PDCO)

Receive News & Ratings for Patterson Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patterson Companies and related companies with MarketBeat.com's FREE daily email newsletter.